Thursday, April 2, 2026
27.6 C
Bengaluru

Pharma CEO Roundtable on 27th October 2021

Engaging Doctors – Physical, Digital & Hybrid: Translating Strategy Into Action

Keynote Address: Rajaram Narayanan, Managing Director, Sanofi India

Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Panel Members:

Digital will NOT make the pharma sales job redundant. Anything else you’ve heard to the contrary – is a MYTH. In fact, digital technology, digital platforms, and digital tools are an enabler for any Pharma salesperson to execute with sharper impact and reduce wastage.

How will this happen? Join us on the 27th of October as we bring together veterans of the industry and discuss what it truly means to go digital, understand the customer journey, identify the gaps, and leverage content via the right channels.

Highlights of the Pharma CEO Roundtable 2021

  • Mapping the customer journey
  • Identifying and filling the need-gaps of doctors
  • Content curation: What is engaging and why does it matter?
  • The omnichannel approach
  • The Sanofi experience

So, cast your inhibitions and fears away – and jump on the digital bandwagon. Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Hot this week

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Healthcare and Gulf War: When Elephants Fight, the Grass Gets Trampled

From Gas Cylinders to ICU Beds: How the Gulf...

Topics

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...

Excellence or Mediocrity—What Are You Building?

Excellence is a choice. So is Mediocrity Excellence is a...

Gila Monster Venom: The Unexpected Spark of the GLP-1 Revolution

In the blistering Sonoran Desert, where temperatures regularly exceed...
spot_img

Related Articles

spot_imgspot_img